Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Noevir Holdings Co., Ltd. ( (JP:4928) ) is now available.
Noevir Holdings reported a weak start to the fiscal year ending September 30, 2026, with first-quarter consolidated net sales down 7.9% year on year to ¥15.47 billion and operating income plunging 29.0% to ¥2.25 billion, while ordinary income fell 26.2%. Despite the slowdown in top-line growth and profit compression, net income attributable to owners of the parent rose 35.7% to ¥1.32 billion, lifting earnings per share to ¥38.70, though the company’s equity ratio slipped to 67.4% as total assets and net assets both declined from the prior fiscal year-end. Management kept its full-year forecast unchanged, targeting marginal growth in net sales and low single-digit increases in operating and net income, and reiterated its plan to maintain a total annual dividend of ¥230 per share, underscoring a commitment to shareholder returns even amid softer quarterly performance.
The most recent analyst rating on (JP:4928) stock is a Buy with a Yen5158.00 price target. To see the full list of analyst forecasts on Noevir Holdings Co., Ltd. stock, see the JP:4928 Stock Forecast page.
More about Noevir Holdings Co., Ltd.
Noevir Holdings Co., Ltd. is a Japan-based cosmetics and personal care group listed on the Tokyo Stock Exchange Prime Market. Operating primarily under the beauty and skincare segment, it develops and sells cosmetics and related products, targeting domestic consumers while maintaining a stable shareholder return policy through consistent dividend payments.
Average Trading Volume: 60,596
Technical Sentiment Signal: Buy
Current Market Cap: Yen160.9B
Learn more about 4928 stock on TipRanks’ Stock Analysis page.